文献速递产科生殖医学

血清可溶性程序性细胞死亡配体-1水平降低作为稽留流产的潜在生物标志物

Decreased serum soluble programmed cell death ligand-1 level as a potential biomarker for missed miscarriage.
PubMed 文献 · Hum Reprod · 2023-01-01

研究探讨母体血清可溶性程序性细胞死亡-1(sPD-1)及其配体(sPD-L1)能否作为稽留流产(MM)的生物标志物。发现队列中MM患者血清sPD-L1较健康孕妇降低约50%,验证队列中MM患者低于人工流产者且胎盘PD-L1表达下调;IVF队列中sPD-L1变化率预测流产的ROC为0.73。

要点

  • MM患者血清sPD-L1较健康孕妇降低约50%(55.7±16.04 pg/ml vs 106.7±58.46 pg/ml,P<0.001)。
  • MM患者血清sPD-L1低于人工流产者,胎盘PD-L1相关基因表达下调。
  • IVF队列中sPD-L1变化率预测流产的ROC=0.73(95%CI:0.57-0.88,P<0.01)。

核心结论

  • MM患者血清sPD-L1水平显著降低,可能作为流产的潜在预测生物标志物。
  • 循环sPD-L1降低及胎盘PD-L1表达下调提示PD-L1信号功能障碍可能是妊娠丢失的潜在机制。

研究设计与样本

  • 三个独立队列于三级转诊医院开展:第一个为横断面发现队列,纳入MM患者与BMI匹配的健康孕妇(HP)。
  • 第二个验证队列纳入MM患者与合法人工流产(IA)妇女。
  • 第三个为前瞻性观察研究,招募需IVF治疗者。
  • 发现队列纳入108例MM患者和115例孕6-14周足月妊娠的健康孕妇。
  • 验证队列招募25例MM患者和25例IA妇女;前瞻性队列每周采集75名IVF胚胎移植(ET)后志愿者的系列血样。

主要发现

  • MM患者循环sPD-L1较HP对照降低50%(55.7±16.04 pg/ml vs 106.7±58.46 pg/ml,P<0.001),校正母亲年龄和孕龄后差异仍显著。
  • sPD-1水平未见显著差异。
  • MM患者血清sPD-L1低于IA者,并伴胎盘PD-L1相关基因表达下调。
  • IVF队列中,应用ET后sPD-L1水平变化率预测流产的ROC=0.73(95%CI:0.57-0.88,P<0.01)。

临床怎么用

  • 作者认为血清sPD-L1水平降低可能作为流产的潜在预测生物标志物。
  • 作者指出PD-L1信号功能障碍可能是妊娠丢失的潜在机制,并扩展了PD-L1轴在早期妊娠维持中的重要性。

局限性

  • 研究主要限于东亚妊娠妇女。
  • 需进一步开展大型前瞻性妊娠队列验证sPD-L1对流产的预测性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can maternal serum levels of soluble programmed cell death-1 (sPD-1) and its ligand (sPD-L1) serve as biomarkers for missed miscarriage (MM)? SUMMARY ANSWER: Serum sPD-L1 levels are significantly decreased in MM patients and may serve as a potential predictive biomarker for miscarriage. WHAT IS KNOWN ALREADY: Programmed cell death-1 (PD-1) and its ligand (PD-L1) comprise important immune inhibitory checkpoint signaling to maintain pregnancy. Their soluble forms are detectable in human circulation and are associated with immunosuppression. STUDY DESIGN, SIZE, DURATION: Three independent cohorts attending tertiary referral hospitals were studied. The first (discovery) cohort was cross-sectional and included MM patients and healthy pregnant (HP) women matched on BMI. The second validation cohort contained MM patients and women with legally induced abortion (IA). The third prospective observational study recruited subjects requiring IVF treatment. PARTICIPANTS/MATERIALS, SETTING, METHODS: In the discovery cohort, we enrolled 108 MM patients and 115 HP women who had a full-term pregnancy at 6-14 weeks of gestation. In the validation cohort, we recruited 25 MM patients and 25 women with IA. Blood samples were collected at the first prenatal visit for HP women or on the day of dilatation and curettage surgery (D&C) for MM and IA subjects to determine serum sPD-1 and sPD-L1 levels. Placenta samples were harvested during the D&C within the validation cohort to measure gene and protein expression. The prospective cohort collected serial blood samples weekly from 75 volunteers with embryo transfer (ET) after IVF. MAIN RESULTS AND THE ROLE OF CHANCE: Circulating sPD-L1 levels were reduced by 50% in patients with MM (55.7 ± 16.04 pg/ml) compared to HP controls (106.7 ± 58.46 pg/ml, P < 0.001) and the difference remained significant after adjusting for maternal age and gestational age, whereas no significant differences in sPD-1 level were observed. Likewise, serum sPD-L1 was lower in MM patients than in IA subjects and accompanied by downregulated PD-L1-related gene expression levels in the placenta. In the IVF cohort, applying the changing rate of sPD-L1 level after ET achieved a predictive performance for miscarriage with receiver operating characteristics = 0.73 (95% CI: 0.57-0.88, P < 0.01). LIMITATIONS, REASONS FOR CAUTION: The study was mainly confined to East Asian pregnant women. Further large prospective pregnancy cohorts are required to validate the predictive performance of sPD-L1 on miscarriage. WIDER IMPLICATIONS OF THE FINDINGS: Reduced circulating sPD-L1 level and downregulated placental PD-L1 expression in miscarriage indicate that dysfunction in PD-L1 signals is a potential underlying mechanism for pregnancy loss. Our findings further extend the importance of the PD-L1 axis in pregnancy maintenance in early pregnancy. STUDY FUNDING/COMPETING INTEREST(S): This study was financially supported by grants from the Subject Innovation Team of Shaanxi University of Chinese Medicine (2019-Y502), General Research Fund (14122021), and Key Laboratory of Model Animal Phenotyping and Basic Research in Metabolic Diseases (2018KSYS003). The authors declare that they have no competing interests to be disclosed. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Li Q, Chen C, Wu J, et al. Decreased serum soluble programmed cell death ligand-1 level as a potential biomarker for missed miscarriage. Hum Reprod. 2023. PMID: 37671597. doi:10.1093/humrep/dead178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。